Offstream
news

South Korea approves the use of the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 5 and 11 years.
2022-02-23

The Philippine Food and Drug Administration approves the emergency use of the Molnupiravir drug made by Merck & Co. for high-risk adult patients and also approves the use of the Pfizer-BioNTech COVID-19 vaccine for children between the ages of 5 and 11 years.
2021-12-23

The South African Health Products Regulatory Authority approves the Pfizer-BioNTech COVID-19 vaccine booster dose for people over the age of 18 that can be administered six months after their second dose, as well as immunocompromised people aged above 12 years that can be administered 28 days after their second dose.
2021-12-8

The South African Health Products Regulatory Authority rejects the Sputnik V COVID-19 vaccine due to some safety concerns the manufacturer wasn’t able to answer such as failed HIV vaccines that use Adenovirus Type 5 that are similar to the Russian-made vaccine.
2021-10-19

A panel of health experts advising the Hong Kong government recommends that children between the ages of 12 and 17 years old should only receive a single dose of the Pfizer–BioNTech COVID-19 vaccine after reports of heart inflammation as a side effect.
2021-09-16

The Pentagon announces that COVID-19 vaccinations will be mandatory for the U.S. military after the FDA approved the vaccine developed by Pfizer and BioNTech.
2021-08-25

The Biden administration announces that beginning on September 20, the U.S. will begin administering booster shots of the Moderna and Pfizer–BioNTech vaccines for most people who received their second dose at least eight months ago.
2021-08-18

The European Commission signs a new deal with Pfizer and BioNTech to purchase 900 million doses of its vaccine with an additional option to purchase another 900 million doses for delivery from 2021 to 2023 which they intend to use as booster shots against the illness and to allow for the vaccination of children and teenagers.
2021-05-8

Medsafe provisionally approves the use of the Pfizer–BioNTech vaccine in New Zealand with certain conditions.
2021-02-3

Canadian Prime Minister Justin Trudeau announces that the country will double its order of the Pfizer-BioNTech vaccine from 20 million to 40 million doses.
2021-01-12